Explore our premium grade active raw materials manufactured under certified ISO quality management protocols.
A comprehensive analysis for chemical procurement directors, formulation scientists, and contract manufacturing organizations (CMOs).
Azelaic Acid is a naturally occurring saturated dicarboxylic acid (HOOC(CH2)7COOH) renowned for its multifunctional therapeutic properties in topical dermatology. It exerts a potent competitive inhibition on tyrosinase, reducing hyperpigmentation and post-inflammatory erythema (PIE). Furthermore, it normalizes follicular keratinization and acts as a selective 5-alpha-reductase inhibitor, controlling sebum oxidation and bacterial proliferation (Propionibacterium acnes) without inducing antimicrobial resistance.
Hyaluronic Acid (Sodium Hyaluronate) is a biopolymer nonsulfated glycosaminoglycan composed of repeating D-glucuronic acid and N-acetyl-D-glucosamine disaccharide units. Acting as an extracellular hydration reservoir, HA holds up to 1,000 times its molecular weight in water. Combining varied molecular weights—from High MW (>1.8 MDa) for film-forming surface barrier retention to Oligo-HA (<10 kDa) for deep dermal penetration—ensures multi-depth hydration.
Formulation Synergy Insight: Azelaic Acid, while remarkably effective for acne, rosacea, and melasma, can cause localized skin dryness or mild desquamation at active concentrations (10% to 20%). Integrating pharmaceutical-grade Hyaluronic Acid buffers the micro-inflammatory response, stabilizes epidermal barrier lipids, and dramatically increases patient/consumer compliance by counteracting trans-epidermal water loss (TEWL).
| Parameter | Azelaic Acid (Cosmetic / Pharma Grade) | Hyaluronic Acid (Multi-MW Formulations) |
|---|---|---|
| Chemical Formula / Structure | C9H16O4 (Dicarboxylic Acid) | (C14H21NO11n) (Glycosaminoglycan) |
| Assay / Purity | ≥ 99.5% (HPLC Verified) | ≥ 95.0% Sodium Hyaluronate (Glucuronic Acid ≥ 46%) |
| Solubility Profile | Slightly soluble in water; soluble in glycolic/ethanolic systems | Freely soluble in aqueous phase; forms viscoelastic hydrogel |
| Optimal Formulation pH Range | pH 4.0 – 5.5 | pH 5.0 – 7.0 |
| Primary Bio-Action | Keratolytic, Anti-Tyrosinase, Anti-Acne, Anti-Rosacea | Deep Hydration, Barrier Repair, ECM Stabilization |
Understanding market demand shifts, regulatory standards, and supply chain dynamics across North America, Europe, and Asia-Pacific.
The global cosmeceutical active market is experiencing an unprecedented CAGR of 8.4%. Azelaic Acid and Hyaluronic Acid represent two of the fastest-growing functional actives, driven by consumer demand for clinical-grade clean beauty, dermatological anti-acne solutions, and post-procedural aesthetic care products.
Compliance under EU Cosmetic Regulation (EC) No 1223/2009, US FDA MoCRA standards, and China NMPA registration requires raw material manufacturers to deliver zero-impurity batches with robust batch-to-batch traceability, heavy metal analysis (<5 ppm), and microbiological sterility verification.
Global formulation brands are migrating away from single-source distributors toward direct integration with primary chemical synthesis and bio-fermentation manufacturers. Direct sourcing ensures structural price stability, custom particle-size milling (micronized Azelaic Acid), and tailored MW HA ratios.
Innovative continuous-flow chemical processing, microbial fermentation, and encapsulation technologies.
Our advanced industrial synthesis utilizes eco-friendly catalytic oxidation of oleic acid derivatives (ozonolysis-free continuous flow reactor chemistry). This proprietary green oxidation process yields high-purity crystalline powder with minimal mono-carboxylic acid impurities, optimized particle size distribution (<15 microns for micronized grades), and exceptional suspension stability in water-in-oil and oil-in-water emulsions.
Produced via non-hemolytic Streptococcus zooepidemicus fermentation using plant-derived glucose substrates. Controlled enzymatic degradation technology allows precise tuning of dalton weights—ranging from 3 kDa (Oligo-HA) to 2.0 MDa. Ultra-filtration and alcohol crystallization yield pyrogen-free powder suitable for topicals, medical hydrogels, and injectable aesthetic formulations.
Encapsulating Azelaic Acid into lipid nanocarriers (SLNs) reduces localized stinging, controls active release over 12 hours, and eliminates formulation gritty feel.
Sodium Hyaluronate Crosspolymer creates a 3D breathable moisture mesh on the stratum corneum, enhancing the prolonged delivery of co-formulated active ingredients.
Proprietary glycol-ester co-solvent vehicle solutions prevent recrystallization of Azelaic Acid in clear gel matrices without high alcohol content.
Integrating research, large-scale industrial manufacturing, digital quality control, and global logistics execution.
Established in 2010 and headquartered in the prestigious Chemical Industry Park of Jinan City, Shandong Province, JIMPOCHEM CO., LTD operates an ultra-modern chemical manufacturing complex spanning over 500 acres. As a leading fine chemical and cosmetic raw material manufacturer, we combine continuous R&D with high-capacity digitalized chemical reaction systems.
Leveraging direct access to foundational chemical feedstocks in Shandong's petrochemical cluster, JIMPOCHEM guarantees complete supply chain immunity against raw material volatility. Our automated batching and digital process controls allow us to deliver thousands of metric tons annually while maintaining rigorous batch-to-batch consistency.
Commercial formulation frameworks for skincare, clinical dermatology, and specialized personal care lines.
Active Ratio: 10% Micronized Azelaic Acid + 0.5% Multi-MW Hyaluronic Acid + 1% N-Acetyl-D-Glucosamine.
Benefit: Targeted treatment for acne vulgaris and papulopustular rosacea with maximum skin barrier protection and zero redness flare-ups.
Active Ratio: 5% Azelaic Acid + 1.5% Hydrolyzed & High MW HA Complex + Glutathione.
Benefit: Accelerated re-epithelialization following chemical peels, microneedling, or ablative fractional laser resurfacing.
Active Ratio: 12% Azelaic Acid + 2% Ethyl Ascorbic Acid + 1% Tranexamic Acid + 0.2% HA.
Benefit: Multi-pathway melanogenesis inhibition targeting stubborn melasma, sun spots, and post-inflammatory hyperpigmentation (PIH).
Comprehensive regulatory document packages provided with every commercial batch order.
Full EU REACH registration dossier, US FDA DMF documentation, and INCI compliant labeling datasets.
Every lot tested via HPLC, GC-MS, ICP-MS (heavy metals), and microbial plate counts. Full COA provided.
GHS-compliant SDS in over 25 global languages, detailing storage parameters, transport, and handling.
HS Code verification (Azelaic Acid HS: 291719; Hyaluronic Acid HS: 391390), DDP/FOB/CIF shipping flexibility.
Explore JIMPOCHEM's full array of organic intermediates, active pharmaceutical ingredients (APIs), and daily chemical inputs.
Detailed technical, regulatory, and procurement insights addressing core formulation and sourcing inquiries.
Direct manufacturer procurement with verified quality certificates and global door-to-door delivery.
JIMPOCHEM